Capricor Therapeutics, Inc. (NASDAQ:CAPR)
Capricor Therapeutics, Inc. (NASDAQ:CAPR) represented a move of 0 percent or $0.05 per share and closed its previous day trading session at $0.75. 0 Shares were traded in the last trading session with an Average Volume of 121.49 Million Shares. The stock currently has a Market Capitalization of 24.29 Million.
Capricor Therapeutics, Inc. is a biotechnology company. It is focused on the development of novel therapeutics to prevent and treat heart disease. The Company has two drug candidates in development: Cenderitide and CU-NP. Capricor Therapeutics, Inc., formerly known as Nile Therapeutics, Inc., is based in San Mateo, California.
The stock traded between $0.660 and $2.290 over 1-Year time period showing its price to sales ratio of 16.19. Capricor Therapeutics, Inc. (NASDAQ:CAPR) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-18.11 and 200-Day Simple Moving Average of $-39.81. Its Price to Free Cash Flow is 0 and Price to Book of 3.26.
Analyst’s recommended the stock as 2 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Capricor Therapeutics, Inc. (NASDAQ:CAPR) reported its Actual EPS of $-0.14/share. The analysts offering Earnings Estimates for the company were believing that Capricor Therapeutics, Inc. could bring EPS of $-0.15/share. The difference between Actual EPS and Estimated EPS was 0.01 Percent. Thus showing an Earnings Surprise of 6.7 Percent.
KCAP Financial, Inc. (NASDAQ:KCAP)
In the last trading session, KCAP Financial, Inc. (NASDAQ:KCAP) added its value by 0% closing at the price of $3.02. The stock currently has market capitalization of 112.79 Million, with average volume of 80.47 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently KCAP Financial, Inc. (NASDAQ:KCAP) is showing beta of 0. This particular value of beta suggests that KCAP Financial, Inc. (NASDAQ:KCAP) has historically moved 0% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for KCAP Financial, Inc. (NASDAQ:KCAP) is at $0.1.
The stock currently has RSI of 40.79. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
KCAP Financial Inc. is an internally managed business development company. The Company’s middle market investment business originates, structures, finances and manages a portfolio of term loans, mezzanine investments and selected equity securities in middle market companies. KCAP Financial Inc., formerly Kohlberg Capital Corp., is based in the New York.
KCAP Financial, Inc. (NASDAQ:KCAP) topped its 52-week high price of $3.58 on 01/03/18 and 52-Week Low Price of $2.91 on 02/28/18. The Stock currently has P/E (price to earnings ttm) of 30.2 and Weekly volatility of 1.86% and monthly volatility of 2.12% respectively.